Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 3/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | GART | P22102 | 1/20 | 0.46 |
| ▸ | ATIC | P31939 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4925425 | 1.00 | ALB (0.50) | ALBFOLH1NAALAD2SMN1; SMN2GART | |
| SCHEMBL4919361 | 0.87 | NAALAD2 (0.61) | FOLH1NAALAD2SMN1; SMN2HDAC1 | |
| SCHEMBL4919365 | 0.87 | NAALAD2 (0.61) | FOLH1NAALAD2SMN1; SMN2HDAC1 | |
| SCHEMBL18725624 | 0.86 | ALB (0.62) | ALBFOLH1 | |
| SCHEMBL18725625 | 0.86 | ALB (0.62) | ALBFOLH1 | |
| SCHEMBL29798933 | 0.86 | FOLH1 (0.65) | FOLH1 | |
| SCHEMBL2330781 | 0.86 | ALDH1A1 (0.54) | ALB | |
| SCHEMBL20100671 | 0.83 | ITGB3 (0.47) | ALBNOD1HDAC1 | |
| SCHEMBL18145804 | 0.82 | FOLH1 (0.60) | FOLH1 | |
| SCHEMBL14729476 | 0.82 | FOLH1 (0.60) | FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080269282-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | GENMEDICA THERAPEUTICS SL (ES) | 2008-10-30 | — | — | US | claimed |
| US-20070066646-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | GENMEDICA THERAPEUTICS SL (ES) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269282-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | AOC2, AOC3, AOC1 | ALB 1078/4885FOLH1 1671/4885NAALAD2 1636/4885 |
| US-20070066646-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | AOC2, AOC3, AOC1 | ALB 1003/4885FOLH1 1974/4885NAALAD2 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.